These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8895183)

  • 1. Analysis of Centers for Disease Control and Prevention criteria for the eosinophilia-myalgia syndrome in a geographically defined population.
    Spitzer WO; Haggerty JL; Berkson L; Davis W; Palmer W; Tamblyn R; Laprise R; Mulder LJ
    J Rheumatol Suppl; 1996 Oct; 46():73-9; discussion 79-80. PubMed ID: 8895183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilia-myalgia syndrome among the non-L-tryptophan users and pre-epidemic cases.
    Sullivan EA; Staehling N; Philen RM
    J Rheumatol; 1996 Oct; 23(10):1784-7. PubMed ID: 8895159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Criteria for the definition of the eosinophilia-myalgia syndrome.
    Hertzman PA
    J Rheumatol Suppl; 1996 Oct; 46():7-12. PubMed ID: 8895176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic bias in clinical decision making: an example of L-tryptophan and the diagnosis of eosinophilia-myalgia syndrome.
    Wagner KR; Elmore JG; Horwitz RI
    J Rheumatol; 1996 Dec; 23(12):2079-85. PubMed ID: 8970044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilia-myalgia syndrome: mortality data from the US national surveillance system.
    Swygert LA; Back EE; Auerbach SB; Sewell LE; Falk H
    J Rheumatol; 1993 Oct; 20(10):1711-7. PubMed ID: 8295183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The natural history of eosinophilia-myalgia syndrome in a tryptophan-exposed cohort in South Carolina.
    Sullivan EA; Kamb ML; Jones JL; Meyer P; Philen RM; Falk H; Sinks T
    Arch Intern Med; 1996 May; 156(9):973-9. PubMed ID: 8624177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuing occurrence of eosinophilia myalgia syndrome in Canada.
    Spitzer WO; Haggerty JL; Berkson L; Davis W; Palmer W; Tamblyn R; Laprise R; Faith JM; Elmore JG; Horwitz RI
    Br J Rheumatol; 1995 Mar; 34(3):246-51. PubMed ID: 7728400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bias or biology: evaluating the epidemiologic studies of L-tryptophan and the eosinophilia-myalgia syndrome.
    Horwitz RI; Daniels SR
    J Rheumatol Suppl; 1996 Oct; 46():60-72. PubMed ID: 8895182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The eosinophilia-myalgia syndrome: what we know, what we think we know, and what we need to know.
    Clauw DJ; Pincus T
    J Rheumatol Suppl; 1996 Oct; 46():2-6. PubMed ID: 8895175
    [No Abstract]   [Full Text] [Related]  

  • 10. A diagnostic algorithm for distinguishing the eosinophilia-myalgia syndrome from fibromyalgia and chronic myofascial pain.
    Taylor RM; Gabriel SE; O'Fallon WM; Bowles CA; Duffy J
    J Rheumatol Suppl; 1996 Oct; 46():13-8. PubMed ID: 8895177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Eosinophilia-myalgia syndrome].
    Kotake S; Kashiwazaki S
    Nihon Rinsho; 1992 Jul; 50(7):1650-5. PubMed ID: 1404896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for developing eosinophilia myalgia syndrome among L-tryptophan users in New York.
    Back EE; Henning KJ; Kallenbach LR; Brix KA; Gunn RA; Melius JM
    J Rheumatol; 1993 Apr; 20(4):666-72. PubMed ID: 8496862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced severity of eosinophilia-myalgia syndrome associated with the consumption of vitamin-containing supplements before illness.
    Hatch DL; Goldman LR
    Arch Intern Med; 1993 Oct; 153(20):2368-73. PubMed ID: 8215741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tryptophan produced by Showa Denko and epidemic eosinophilia-myalgia syndrome.
    Kilbourne EM; Philen RM; Kamb ML; Falk H
    J Rheumatol Suppl; 1996 Oct; 46():81-8; discussion 89-91. PubMed ID: 8895184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophilia-myalgia syndrome in patients ingesting a single source of L-tryptophan.
    Henning KJ; Jean-Baptiste E; Singh T; Hill RH; Friedman SM
    J Rheumatol; 1993 Feb; 20(2):273-8. PubMed ID: 8474064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of L-tryptophan and eosinophilia-myalgia syndrome.
    Roufs JB
    J Am Diet Assoc; 1992 Jul; 92(7):844-50. PubMed ID: 1624654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-tryptophan-related eosinophilia-myalgia syndrome: a case report.
    Wong CB; Love J; Pon E; Scottolini AG; Manoukian AA
    Hawaii Med J; 1990 Aug; 49(8):295-8, 303. PubMed ID: 2211094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upper extremity contractures in a patient with eosinophilia-myalgia syndrome.
    Marchman HB; Gleason CB; Shaw JC
    Arch Phys Med Rehabil; 1991 Nov; 72(12):1029-30. PubMed ID: 1953317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiologic studies of the association of L-tryptophan with the eosinophilia-myalgia syndrome: a critique.
    Shapiro S
    J Rheumatol Suppl; 1996 Oct; 46():44-58; discussion 58-9. PubMed ID: 8895181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibromyalgia, psychiatric disorders, and assessment of the longterm outcome of eosinophilia-myalgia syndrome.
    Hudson JI; Pope HG; Carter WP; Daniels SR
    J Rheumatol Suppl; 1996 Oct; 46():37-42; discussion 42-3. PubMed ID: 8895180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.